Results 171 to 180 of about 84,402,451 (356)

Pinatubo: A processing-in-memory architecture for bulk bitwise operations in emerging non-volatile memories

open access: yesDesign Automation Conference, 2016
Shuangchen Li   +5 more
semanticscholar   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi   +5 more
wiley   +1 more source

Spatial and Volumetric Characteristics of Glioblastoma: Associations With Clinical Presentation and Survival

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou   +16 more
wiley   +1 more source

Executive functions, processing speed, and memory performance: Untangling the age-related effects

open access: yesJournal of Psychiatry Spectrum
Context: Age-related decline in memory function is a universal phenomenon. However, several factors are known to affect memory decline associated with aging.
Bhaswati Saikia, Ravikesh Tripathi
doaj   +1 more source

Impact of Plasma p‐tau181 on Cognition, Motor Phenotypes, and Disease Course in ALS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Phosphorylated tau181 (p‐tau181), an Alzheimer's disease biomarker, was recently evaluated in amyotrophic lateral sclerosis (ALS). We investigated plasma p‐tau181 in 202 ALS/ALS‐FTD patients and 94 healthy controls, assessing cognitive performance, motor function, and longitudinal dynamics.
Elisabeth Kasper   +25 more
wiley   +1 more source

Role of the hippocampus in systems consolidation of remote fear memory

open access: yesExperimental and Molecular Medicine
For decades, the processing and retrieval of memories over weeks or even years have been crucial and fundamental subjects in neuroscience. The hippocampus is essential for episodic memory, including associative fear memory.
Hyunmin Park, Bong-Kiun Kaang
doaj   +1 more source

Memory, citizenship and social behaviour : Can we (really) learn from the past?

open access: yes, 2015
Sarah Gensburger et Sandrine Lefranc (CNRS – ISP – Université Paris Ouest – ENS Cachan) In this research we seek to challenge the widespread belief that remembering our past is necessary for preserving peace and democracy and that we can “learn” from the
Women Memory
core  

Metabolic and Microvascular Risk Factors Associated With Brain Health in Type 1 Diabetes

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT We examined relationships between metabolic factors, microvascular complications, and brain health in adults with type 1 diabetes. Fifty‐one adults were assessed for metabolic risk factors, microvascular complications, and cognitive function, with a subset completing brain MRI.
Jihyun Park   +7 more
wiley   +1 more source

A Comparative Study of Digital Memristor‐Based Processing‐In‐Memory from a Device and Reliability Perspective

open access: yesAdvanced Electronic Materials
As data‐intensive applications increasingly strain conventional computing systems, processing‐in‐memory (PIM) has emerged as a promising paradigm to alleviate the memory wall by minimizing data transfer between memory and processing units.
Thomas Neuner   +5 more
doaj   +1 more source

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy